Skip to main content


Intravitreal injection linked to substantial temporary blood pressure increase


Patients undergoing intravitreal injections with anti–vascular endothelial growth factor agents can experience substantial transient increases in systolic blood pressure, Swiss researchers report.

09-08-2019 | Rheumatology | News | Article

GCA no less common in Black than White individuals

The incidence of giant cell arteritis is similar among Black and White people, suggests an analysis of a cohort from a US tertiary care center.

05-07-2019 | Rheumatology | News | Article

Favorable results with TNF inhibitors in Behçet's disease-associated uveitis

The tumor necrosis factor inhibitors adalimumab and infliximab both show good efficacy when used as first biologic agents in patients with refractory uveitis due to Behçet's disease, Spanish research shows.

17-06-2019 | Rheumatology | News | Article

Further investigation of tocilizumab for JIA-associated uveitis may be warranted

Approximately half of the 21 patients with juvenile idiopathic arthritis-associated uveitis in the APTITUDE trial experienced an improvement in uveitis assessment with 12 weeks of tocilizumab treatment.

07-05-2019 | Rheumatology | News | Article

ACR/National Arthritis Foundation guidelines for managing JIA released

The ACR and the National Arthritis Foundation have published two guidelines on juvenile idiopathic arthritis, one providing recommendations for the treatment of polyarthritis, sacroiliitis, and enthesitis, and the other focusing on detecting and treating uveitis.

Twitter Icon Follow medwireNews

Click here
Image Credits